The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant
Biomolecules, Free Full-Text
Cancers, Free Full-Text
Emerging insights into mechanisms of trastuzumab resistance in
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in
Detailed curriculum vitae of HER2-targeted therapy - ScienceDirect
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in
Cancers, Free Full-Text
An ErbB-2 molecule unable to bind Hsp90 shows enhanced activity
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in
Transcriptomic analysis with HER2 and 611-CTF. (A) Venn diagram
PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple